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ABSTRACT
The relationship between parents and clinician is critical
to the care and treatment of children with life-limiting
conditions (LLCs) and life-threatening illnesses (LTIs).
This relationship is built and maintained largely in
consultations. In this article we lay out factors that bear
on the success of clinical consultations and the
maintenance of the essential clinician–parent
relationship at progression or deterioration of LLCs or
LTIs. We suggest an approach to engaging parents in
conversations about care and treatment that recognises
and appreciates the dilemmas which clinicians and
parents face and in so doing provides a way for
everyone to live with the decisions that are made.
A close analysis of a consultation at progression and
excerpts of encounters among parents, clinician and
researcher are used to illustrate our approach to
research, analysis and development of recommendations
for clinical practice.
INTRODUCTION
Medicine advances; children live longer. Some are
cured of diseases which were thought to be invari-
ably fatal. As treatment options increase so do the
choices and decisions that need to be made.
Depending on the decision taken, harm may be
done and suffering may result. Parents and clini-
cians must live with the decisions they have made.
Critical to decision making is the relationship
between parents and clinicians. This relationship is
built and maintained largely in the consultation. In
this article we lay out factors that bear on the
success of clinical consultations and the mainten-
ance of the essential clinician–parent relationship at
progression or deterioration of life-limiting condi-
tion (LLC) or life-threatening illness (LTI). We
suggest an approach for clinicians to use in
engaging with parents in such conversations about
care and treatment that recognises and appreciates
the dilemmas which clinicians and parents face and
in so doing it provides a way for everyone to live
with the decisions that are made. A close analysis
of a consultation at progression and excerpts of
encounters among parents, clinician and researcher
is used to illustrate our approach to research, ana-
lysis and recommendations for clinical practice
(ﬁgures 1 and 2).
Our approach is based on results of studies of
children with cancer and cystic ﬁbrosis and their
families undertaken by the anthropologist MBL
over the past 40 years.1–6 The perspective from
which these studies were conducted led to import-
ant changes in the way in which we think about ill
children and their families and how we talk with
these children. The studies demonstrated that chil-
dren can and do become aware that they are dying
when no one tells them, that parents and children
protect each other from that awareness through the
practice of mutual pretence and that there are ways
to deal with that mutual pretence without harming
essential relationships between parent and
child.3 6 7
In applying this approach to the complexity of
consultations, we identify problems that can occur
in difﬁcult interactions and how they can be
addressed taking into consideration all perspectives.
The approach, applied here to a case of a child
with a brainstem glioma could also be applied to
difﬁcult decisions in the newborn period, intensive
treatment unit, or indeed in any facet of medicine
that involves decision making among parents, clini-
cians and in some cases children as well.
OUR APPROACH TO STUDY OF THE ILLNESS
EXPERIENCE AND DECISION MAKING
Our approach to research is an in-vivo one. We
capture events as they unfold and record conversa-
tions as they take place. Research begins with
embedding the researcher(s) in the clinical teams,
establishing themselves as participant-observers.
They immerse themselves in the everyday lives of
children, families and clinicians—following them in
hospital, hospice and patients’ homes over the
course of the illness. In time, both clinicians and
families ﬁnd their presence, wherever it is,
unremarkable.
The researcher is present in as many venues in
which care and treatment of children take place
as possible. Researcher(s) attend consultations,
family and multidisciplinary team (MDT) meet-
ings, ward rounds and home visits by healthcare
professionals. They are present in waiting rooms
and talk with parents and clinicians before and
after consultations, rounds and MDT meetings.
All of these interactions, including the open-
ended, semi-structured interviews conducted at
the close of each case are audio-recorded, tran-
scribed verbatim with non-verbal behaviours
inserted into the transcript. Fieldwork is con-
ducted continuously over a relatively long period
(9 months to 2 years).
Following the practise of a cultural anthropolo-
gist, the researcher(s) grasp the participants’—
patients, parents and clinicians—individual
understandings of ideas and issues. Thus, when
investigating a parent’s understanding of treat-
ment options, the researcher(s) construct the
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parent’s point of view from the recorded and observed
conversations.
In taking an ‘in-vivo’ approach, problems of inaccurate or dis-
torted recall from retrospective interviewing are avoided. The
complex interchange is documented as it unfolds. Researchers
capture the different perspectives of the multiple participants in
an interchange. By following MDT meetings and ‘corridor
chats’, for example, differing presentations of information to
parents from different sources can be tracked.
SOME FEATURES OF THE ILLNESS EXPERIENCE THAT BEAR
ON DECISION MAKING
The complex roles of clinicians and parents
Key to understanding decision making with seriously ill children
is the roles which parents and clinicians occupy in their lives.1 2 4
A role is something constitutive of one’s identity and sense of
self. It signiﬁcantly affects how we conduct ourselves in inter-
action with others and how we feel about those interactions.
Part of the role of a parent is to protect and advocate for
their child. This begins with learning at diagnosis how to navi-
gate the healthcare system. Advocating can take the form of
dealing with options for treatment. Protecting involves weighing
the risks which they present. Driven by the need to leave no
stone unturned, parents’ advocacy is tireless.
Just as parents have a socially deﬁned role which comes into
play in decision making so too do clinicians. One important
way clinicians perceive themselves, and how society perceives
them, is as professionals trained to treat.9 A second perception
is that they are ethical practitioners who will recommend within
their realm of expertise what is best for their patients.
Challenges to our understanding of the child
One of the compelling understandings of a child in Western
society is as a being with a future.1 5 This is the norm. Often a
child with a LLC or LTI challenges such notions and our con-
structions of what children are.
Diagnosis of LLC or LTI is an assault on the life of the family
The diagnosis of a LLC or a LTI is an assault on the child and
family.2 Receipt of such a diagnosis, or news of progression, is
simultaneously numbing and overwhelming. Plans, roles, duties,
obligations and priorities change to accommodate care and
treatment.
This challenge reappears at each relapse, at each unmet
developmental milestone. The parents’ ability to protect and to
advocate for the ill child and for siblings is constantly being
tested.
Parents’ push back: containing the intrusion of the disease
in everyday family life
Parents push back against the invasion of the disease into their
lives.2 They respond to challenges while trying to preserve what
they can of their normal way of life for as long as possible.
Parents use several strategies to: manage the tasks of care,
process information about the disease and the child’s condition,
assess and address priorities in the family and conceptualise a
future despite the prognosis.
The strategies allow them to live for a period of time with
some sense of normalcy and control. The strategies change
over the course of the illness. For example, in the case of chil-
dren with cystic ﬁbrosis, when the child is doing well, the
parents talk about a future through adulthood, marriage, chil-
dren and a job. When the child’s condition is deteriorating,
the future is reconceptualised to a shorter frame—secondary
school, dating perhaps. When the child is doing well, informa-
tion about the possibilities of gene therapy come to the fore-
front and the possibility of death goes to the back of one’s
mind. It is not forgotten but neither is it the focus. Parents
and siblings engage in a redeﬁnition of normal. The deﬁnition
of what constitutes normal is altered to accommodate the
child’s changing condition and family life.
Individual’s understanding of themselves and of the illness
change over time
The impact of serious illness changes over time. Each disease
has its own biosocial illness trajectory marked by transitional,
signiﬁcant disease-related events.1 2 Within each stage of the tra-
jectory there are changes in the child’s condition and in indivi-
duals’ views of themselves and of the ill child.
Figure 1 ‘A very difﬁcult scenario’: case summary.
Figure 2 Steps to be taken to prevent impasse in the consultation
and breakdown of the parent–clinician relationship.
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Transition to a new stage in the illness trajectory affects the way
in which ill children, their parents and siblings think about the
disease and themselves. For healthy siblings of children with cystic
ﬁbrosis, for example, as their ill sibling moves along the illness tra-
jectory, their descriptions of their sibling’s disease become less
optimistic and they use more qualiﬁers. Eventually, especially as
other ill children whom they know or knew die, their conversa-
tions reﬂect awareness that the death of their sibling is likely or
imminent. Thus, the way in which family members apply concepts
such as prognosis to the ill child is a function, in part, of where
they and their child are, on the illness trajectory.
Parents’ use of information from clinicians is often not as
clinician would expect
The relationship between information conveyed to patients and
families in consultations and decisions made is complex.4 On
the basis of statements and actions of parents in consultations,
preliminary analysis revealed no association between parents’
understanding that there was no cure for their child and
whether they pursued further disease-directed options.
Why do parents search when the odds of ﬁnding anything,
and the odds of success with anything which they might ﬁnd,
are so slight?
Parental focus is on that particular child to whom they bear a
unique responsibility. They must apply the information from the
clinician, at a population level, to one individual, their child. If
they are shown a survival curve, parents seem to realise that
their child could occupy any place on that curve. As one mother
said:
If I decline treatment for him I have denied him that chance.
The odds of a child’s responding to treatment or being cured
are not by themselves determinative of parental choices. Parents
may accept very small odds as worthwhile.
Continuing the search for disease-directed options is crucial
to parents. For example, we found that most parents pursue
treatment in the weeks or even in the days before the child’s
death.4 By pursuing we do not mean that they necessarily are
administering treatment, rather they are continuing to look for
treatment. Parents may do this themselves or ask their consult-
ant to do this or both.
Parents throughout the disease embrace both disease-directed
and symptom-directed goals. This dual pursuit is a reﬂection of
the multifaceted roles which they occupy.
Parental and clinicians’ views of the child are not
necessarily the same
Parents have their own views of their child’s status and well-
being.4 8 These may differ from those of the clinician. As the
disease progresses, clinician and parental assessment of the
child’s condition may diverge. A clinician may see the child as
declining but the parent normalises the child’s condition. As
one mother put it, her son was a ‘healthy sick kid’ and should
be treated as such.
The parents’ construction of the child and their interests are
different and perhaps wider than that of the clinician. The par-
ental view may be driven by factors which the clinician cannot
alter, but can understand.
APPLYING THE AFOREMENTIONED FEATURES TO
UNDERSTANDING THE CONSULTATION
1. An upset mother leaves the consultation (see ﬁgure 1). She
has been told that her daughter’s tumour is growing, that
there is no more treatment and that the child, who appears
stable to her, will deteriorate and will likely die within a few
months.
▸ After the consultation, the doctor says to the researcher,
‘Unsatisfactory’ ‘Absolutely terrible’. ‘Hopeless’. He states
that, “I haven’t been able to address very many issues,
you know, they’re upset”. At the neuro-oncology MDT
meeting the following day the clinician describes the
event to his colleagues as ‘a very difﬁcult scenario’.
▸ A sibling says, “So, are you just going to keep us with her
until she just passes away?” The clinician responds that,
no, not at all, the child will be supported.
2. The mother, siblings and the clinician are disturbed and dis-
satisﬁed with what has happened during the consultation as
well as the situation. Their frustrations can be understood by
appreciating that each is pulled simultaneously in different
directions. They need to respond to the demands of compet-
ing roles without totally neglecting one side or the other.
They need to do this for themselves and for maintaining
their relationship with one another as well as for carrying on
with caring for the child.
▸ The mother’s paramount task is to advocate for her
child. In hours of recorded conversation, she speaks
favourably at various points of those who have ‘helped’
or might help her daughter. That is what she seeks.
▸ Clinicians regard themselves and are regarded by others
as trained to treat.9 This clinician has nothing to offer.
He has asked colleagues, they offer nothing. He conveys
this to the family.
▸ The adult siblings raise questions about the availability of
treatments in other places. The family understands what
they have been told, but as their expectation is that a clin-
ician will treat, they try to continue to interact with him
in terms of the way in which they understand his role.
▸ The imperative to treat is in tension with a second
dimension of the clinician’s role: to protect the child’s
interest and do no harm. For the clinician the overriding
interest of the child now lies in providing the supportive
care she will require over the coming months.
▸ The family recognises that the impetus to ‘try something’
is balanced against the impact of therapy on the child.
But they still wish to explore disease-directed options,
including clinical trials.
3. At the outset of the consultation, the mother and siblings,
on the one hand, and the clinician, on the other hand, are
intent on pursuing one of the two opposing sides of the
roles which they each occupy.
▸ The mother and siblings raise the issue of proton beam
therapy, something which the child had discovered
herself online. The mother and the siblings and indeed
the patient herself are looking for something to ‘try’.
‘Try’ is the word the mother uses, not ‘cure’.
▸ During the consultation the clinician reminds the family
that he had told them at diagnosis that they could control
the disease for some time, but that they could not cure
her. The clinician also assures the family that palliation is
not doing nothing. The child will be supported medically.
▸ Reassurances that symptom care will be provided,
however, do not address the mother’s drive to advocate
for her child. She tells the researcher several times that
the clinician has ‘closed the ﬁle’ on her daughter. She
says that he ‘has made her dead’.
▸ Incumbent on parents is that they must leave no stone
unturned.4 Their child’s death must not be because of
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their failure or inaction. The sibling says: “Because we’re
trying to ﬁnd a different way too—because if you’re
going to help her like you say, like there’s no—we’re
trying our best too, to not feel guilt, like we didn’t do
nothing”.
▸ The clinician tells the researcher that he is distressed
because he was unable to raise with the family issues
about what care the child might need in the near future
and how the family will respond.
4. During the consultation, the family and clinician display dif-
fering perceptions of the clinical status of the child.
▸ The mother sees her daughter as ‘strong’ and ‘clever’.
She has deﬁcits as a result of treatment, but these have
become integrated into a redeﬁned view of normal. The
mother enters and then prematurely exits the consult-
ation with the view that her daughter’s state is stable.
▸ The clinician presents the child as having disease pro-
gression. The clinician assessment is based on clinical
ﬁndings, especially the scan. The mother’s view is
driven by signiﬁcant disease-related experiences. To date
there have been no such new experiences that would
alter her view.
▸ The child has progressed in the clinician’s view, but the
child and family have not advanced on the biopsychoso-
cial illness trajectory. Our perspective suggests that this is
possible since factors that drive the clinician’s view and
those that drive the family’s views are different. The dif-
ferences in the way the child is represented in this con-
sultation make further negotiation about what to do
going forward difﬁcult.
5. The current case illustrates how differences between families
and clinicians can emerge in a consultation. We see how
these can be attributed both to what the parties bring to the
consultation and to what emerges during the interaction in
the consultation. We have identiﬁed, using our perspective,
two important factors in the case at hand.
▸ The ﬁrst factor is which horn of the dilemma each wants
to address at the outset in the consultation: the disease-
directed horn or the overall well-being horn.
▸ The second factor in this case is the way that clinicians and
families perceive or do not perceive signiﬁcant changes in
the child’s status. The clinician was anticipating, hoping
that the family would align their views with his as a result
of his forewarning of disease progression at diagnosis.
▸ One cannot assume that both parties will arrive at the
same point at the same time. Their views are not driven
by the same factors.
ENGAGING WITH PARENTS IN DECISION MAKING
The dilemmas which clinicians and parents face are part of the
fabric of their lives and their relationship. Parents have dual
goals, seeking both disease-directed and symptom-directed
care.4 10 Clinicians do as well. They treat disease, but they also
look after the well-being of their patients and, when that is a
child, the family as well. Applying the perspective presented
above, we see how an interaction and, in turn, a relationship
can break down. Each party needs the other in order to reach
their common goal: to give the ill child the best that is possible.
Each party needs to have their roles and their understandings of
the situation at least implicitly acknowledged by the other party.
When this ceases, interaction is no longer truly possible. An
impasse is reached.
This suggests the need to enter the consultation with aware-
ness of the dilemmas clinicians and parents face as well as the
need to maintain that awareness in the conversation that ensues.
This will help to avoid a fractured relationship which adversely
affects the care of the child and the parents’ well-being in sur-
vivorship or bereavement. We need to rehearse our actions and
our message. We need to carry into the consultation an aware-
ness that this is a two-sided negotiation. We need to speak and
act in a way which prevents breakdown of the consultation and
the relationship (see ﬁgure 2).
Such diligence will lay the foundation for making decisions
we can live with—for we will have done all that is within our
power to do.
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